UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 15, 2008
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in charter)
Maryland | 1-11316 | 38-3041398 |
(State of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
9690 Deereco Road
Suite 100
Timonium, Maryland 21093
(Address of principal executive offices / Zip Code)
(410) 427-1700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act. | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act. | |
o | Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act. | |
o | Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act. |
Item 1.01. | Entry Into a Material Definitive Agreement |
The offered shares were registered under an existing automatic shelf registration statement (the “Registration Statement”) on Form S-3 (Registration No. 333-150183) filed by Omega on April 10, 2008 with the Securities and Exchange Commission (“SEC”), including a related Prospectus as supplemented by a Prospectus Supplement dated September 15, 2008 and filed with the SEC pursuant to Rule 424(b)(2) under the Securities Act of 1933.
A copy of the form of Underwriting Agreement is attached hereto as Exhibit 1.1 and is incorporated by reference herein.
Item 8.01. | Other Events |
The following table is incorporated by reference into Item 14 of Part II of the Registration Statement, and sets forth the estimated expenses in connection with the issuance and distribution of the shares. All of the expenses will be borne by Omega except as otherwise indicated.
SEC Registration Fee | $ | 3,861 | * | |
Accounting Fees and Expenses | $ | 75,000 | ||
Legal Fees and Expenses | $ | 175,000 | ||
Miscellaneous | $ | 21,139 | ||
Total | $ | 275,000 |
______________________
* | Previously paid in connection with unsold securities registered by the Company on Registration Statement No. 333-117655. |
Item 9.01 | Financial Statements and Exhibits | ||
(d) | Exhibits. | ||
Exhibit Number | Description | ||
1.1 | Form of Underwriting Agreement | ||
5.1 | Opinion of Powell Goldstein LLP regarding the legality of the Common Stock being registered | ||
23.1 | Consent of Powell Goldstein LLP (contained in Exhibit 5.1) | ||
99.1 | Press Release dated September 16, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OMEGA HEALTHCARE INVESTORS, INC. | ||
(Registrant) | ||
Dated: September 16, 2008 | By: /s/ Robert O. Stephenson | |
Robert O. Stephenson | ||
Chief Financial Officer |